Hodgie, one thing to consider mate.....I will suggest that the circa 5%
value from Goetz is purely for the partnership with GSK, I don't think
any valuation would be based on pre-clinical research....
The market certainly wouldn't, the news out in the next week or so
will give us a better indication of where 761 is headed.....
just my thoughts...
- Forums
- ASX - By Stock
- Immunotherapy Market value
Hodgie, one thing to consider mate.....I will suggest that the...
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 28.5¢ | $913.3K | 3.099M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 124895 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 30287 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 0.395 |
3 | 76000 | 0.390 |
4 | 68064 | 0.385 |
10 | 225656 | 0.380 |
1 | 8500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 37481 | 2 |
0.410 | 240538 | 10 |
0.415 | 229395 | 10 |
0.420 | 502644 | 9 |
0.425 | 50700 | 3 |
Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |